Abstract:As a powerful tool for genome-wide gene expression analysis, DNA microarray technology is widely used in biomedical research. One important application of microarrays is to identify differentially expressed genes (DEGs) between two distinct biological conditions, e.g. disease versus normal or treatment versus control, so that the underlying molecular mechanism differentiating the two conditions maybe revealed. Mechanistic interpretation of microarray results requires the identification of reproducible and reliable lists of DEGs, because irreproducible lists of DEGs may lead to different biological conclusions. Many vendors are providing microarray platforms of different characteristics for gene expression analysis, and the widely publicized apparent lack of intra- and cross-platform concordance in DEGs from microarray analysis of the same sets of study samples has been of great concerns to the scientific community and regulatory agencies like the US Food and Drug Administration (FDA). In this chapter, we describe the study design of and the main findings from the FDA-led MicroArray Quality Control (MAQC) project that aims to objectively assess the performance of different microarray platforms and the advantages and limitations of various competing statistical methods in identifying DEGs from microarray data. Using large data sets generated on two human reference RNA samples established by the MAQC project, we show that the levels of concordance in inter-laboratory and cross-platform comparisons are generally high. Furthermore, the levels of concordance largely depend on the statistical criteria used for ranking and selecting DEGs, irrespective of the chosen platforms or test sites. Importantly, a straightforward method combining fold-change ranking with a non-stringent P-value cutoff produces more reproducible lists of DEGs than those by t-test P-value ranking. Similar conclusions are reached when microarray data sets from a rat toxicogenomics study are analyzed. The availability of the MAQC reference RNA samples and the large reference data sets provides a unique resource for the gene expression community to reach consensus on the "best practices" for the generation, analysis, and applications of microarray data in drug development and personalized medicine.

APPLICATION OF DIFFERENT MICROARRAY ANALYSIS METHODS IN PHARMACOLOGICAL MECHANISM RESEARCH

Microarray Expression Profiling: Analysis and Applications.

The Application of Novel Multifunctional Microarray Slides for Immobilization Biomolecules

A Comparison Study of Microarrays by Fluorescence Imaging and Surface Plasmon Resonance Imaging

Application of DNA Microarray Technologies in Neurotoxicology Research

Analyzing Microarray Data with Classification and Clustering Methods.

The Microarray Quality Control (Maqc) Project And Cross-Platform Analysis Of Microarray Data

Microarrays: Technologies and Applications

A Robust Statistical Procedure to Discover Expression Biomarkers Using Microarray Genomic Expression Data.

A two-step strategy for detecting differential gene expression in cDNA microarray data

Protein microarrays for studies of drug mechanisms and biomarker discovery in the era of systems biology.

Application of DNA microarray technology in immunological research and its inspiration to researches on traditional Chinese medicine

Common Meta-Analysis Methods of Microarray Data

Identifying differentially expressed genes in human acute leukemia and mouse brain microarray datasets utilizing QTModel

Gcncchip Technology and Its Application in Pharmacology

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies.

High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery

An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection

Statistical methods for analyzing microarray feature data with replications.

Disscusion of Applying GeneChip in Modernization of Traditional Chinese Medicine Research